Lisa Hansen

790 total citations
19 papers, 533 citations indexed

About

Lisa Hansen is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lisa Hansen has authored 19 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Hematology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lisa Hansen's work include Bone health and treatments (3 papers), Cancer Treatment and Pharmacology (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Lisa Hansen is often cited by papers focused on Bone health and treatments (3 papers), Cancer Treatment and Pharmacology (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Lisa Hansen collaborates with scholars based in United States, Denmark and Japan. Lisa Hansen's co-authors include Theodore W. Frick, Michael Corry, Carol M. Moinpour, Frank L. Meyskens, Keith Hansen, Dawn L. Hershman, Danika L. Lew, Joseph M. Unger, James L. Wade and Katherine D. Crew and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Obesity.

In The Last Decade

Lisa Hansen

17 papers receiving 504 citations

Peers

Lisa Hansen

ONCOL

HEMAT

PHYSI

DERMA

GHP

Roger D. Klein United States

Hozefa A. Divan United States

Mark Toynbee United Kingdom

Margaret Barton‐Burke United States

Jane A. Hunt United Kingdom

Rong Fu China

Mi-Kyung Park South Korea

Ruth Baxter United Kingdom

Ysabella Van Sebille Australia

Atiyeh M. Abdallah Qatar

Roger D. Klein United States

Lisa Hansen

107 ×0.4

ONCOL

38 ×0.4

HEMAT

38 ×0.7

PHYSI

28 ×0.5

DERMA

34 ×0.8

GHP

Citations per year, relative to Lisa Hansen Lisa Hansen (= 1×) peers Roger D. Klein

Countries citing papers authored by Lisa Hansen

Since Specialization

Citations

This map shows the geographic impact of Lisa Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Hansen more than expected).

Fields of papers citing papers by Lisa Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Hansen. The network helps show where Lisa Hansen may publish in the future.

Co-authorship network of co-authors of Lisa Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Hansen. A scholar is included among the top collaborators of Lisa Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Hansen. Lisa Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Hansen, Lisa, et al.. (2021). Resolving Pseudohyponatremia: Validation of Plasma Sodium on Radiometer ABL800 Blood Gas Analyzers for Immediate Reflex Testing. Laboratory Medicine. 53(5). e105–e108. 1 indexed citations

Poznak, Catherine Van, Joseph M. Unger, Amy K. Darke, et al.. (2020). Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer. JAMA Oncology. 7(2). 246–246. 49 indexed citations

Poznak, Catherine Van, Joseph M. Unger, Amy K. Darke, et al.. (2019). Osteonecrosis of the jaw in patients with cancer receiving zoledronic acid for bone metastases: SWOG S0702, NCT00874211.. Journal of Clinical Oncology. 37(15_suppl). 11502–11502. 6 indexed citations

Greenlee, Heather, Danika L. Lew, Dawn L. Hershman, et al.. (2018). Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008). Obesity. 26(10). 1539–1549. 5 indexed citations

Hansen, Lisa, et al.. (2017). Innovative pilot to reimburse nurse and social work-led advance care planning.. Journal of Clinical Oncology. 35(31_suppl). 3–3. 1 indexed citations

Greenlee, Heather, Katherine D. Crew, Jillian L. Capodice, et al.. (2015). Methods to Standardize a Multicenter Acupuncture Trial Protocol to Reduce Aromatase Inhibitor-related Joint Symptoms in Breast Cancer Patients. Journal of Acupuncture and Meridian Studies. 8(3). 152–158. 7 indexed citations

Greenlee, Heather, Danika L. Lew, Dawn L. Hershman, et al.. (2015). Phase II feasibility study of a physical activity and dietary change weight loss intervention in a subset analysis of breast cancer survivors (SWOG S1008).. Journal of Clinical Oncology. 33(15_suppl). 9572–9572. 2 indexed citations

Hershman, Dawn L., Joseph M. Unger, Katherine D. Crew, et al.. (2014). Omega-3 fatty acids for aromatase inhibitor–induced musculoskeletal symptoms in women with early-stage breast cancer (SWOG S0927).. Journal of Clinical Oncology. 32(15_suppl). 9532–9532. 2 indexed citations

Henry, N. Lynn, Joseph M. Unger, Anne F. Schott, et al.. (2014). A randomized placebo-controlled phase III study of duloxetine for treatment of aromatase inhibitor (AI)-associated musculoskeletal symptoms in women with early-stage breast cancer: SWOG S1202.. Journal of Clinical Oncology. 32(15_suppl). TPS9662–TPS9662. 3 indexed citations

10.

Hershman, Dawn L., Joseph M. Unger, Katherine D. Crew, et al.. (2013). Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy. Journal of Clinical Oncology. 31(20). 2627–2633. 145 indexed citations

11.

Hansen, Lisa, et al.. (2013). Enhancing Nurse Contributions to SWOG Clinical Trials. Seminars in Oncology Nursing. 30(1). 26–31. 2 indexed citations

12.

Hershman, Dawn L., Joseph M. Unger, Katherine D. Crew, et al.. (2012). SWOG S0715: Randomized placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy during adjuvant breast cancer therapy.. Journal of Clinical Oncology. 30(15_suppl). 9018–9018. 3 indexed citations

13.

Fowler, Cedar, Keith Hansen, Lisa Hansen, et al.. (2009). Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience. Bone Marrow Transplantation. 43(12). 909–917. 57 indexed citations

14.

Hansen, Keith, et al.. (2008). Rhizobium radiobacter as an opportunistic pathogen in central venous catheter-associated bloodstream infection: case report and review. Journal of Hospital Infection. 68(3). 203–207. 37 indexed citations

15.

Eldredge, Deborah H., et al.. (2006). Explaining Family Caregiver Role Strain Following Autologous Blood and Marrow Transplantation. Journal of Psychosocial Oncology. 24(3). 53–74. 36 indexed citations

16.

Hansen, Lisa, et al.. (2006). Glutamine supplementation to reduce oral mucositis in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation: A feasibility study. Biology of Blood and Marrow Transplantation. 12(2). 144–144. 1 indexed citations

17.

Maziarz, Richard T., Lisa Hansen, Keith Hansen, et al.. (2006). Rescue from Failed Growth Factor and/or Chemotherapy HSC Mobilization with G-CSF and AMD3100: An Institutional Experience.. Blood. 108(11). 5460–5460. 1 indexed citations

18.

Hansen, Lisa, Polly Feigl, Manuel Modiano, et al.. (2005). An Educational Program to Increase Cervical and Breast Cancer Screening in Hispanic Women. Cancer Nursing. 28(1). 47–53. 81 indexed citations

19.

Corry, Michael, Theodore W. Frick, & Lisa Hansen. (1997). User-centered design and usability testing of a web site: An illustrative case study. Educational Technology Research and Development. 45(4). 65–76. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact